Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Bujanda

Showing results (351-360 of 423) with videos related to

Pageof 43
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severityPhilip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 3, 2021
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involvedLuis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
Helicobacter|July 14, 2020
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)Olga P Nyssen, Angeles Perez-Aisa, Luis Rodrigo, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
The Role of Statins on <i>Helicobacter pylori</i> Eradication: Results from the European Registry on the Management of <i>H. pylori</i> (Hp-EuReg)María Caldas, Ángeles Pérez-Aisa, Bojan Tepes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 13, 2019
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of PatientsAdrian G McNicholl, Dmitry S Bordin, Alfredo Lucendo, et al.
BJS Open|March 31, 2026
Accuracy and variability of locoregional staging in T1 rectal cancer: nationwide multicentre cohort studyMaria Daca-Alvarez, Cristina Manzotti, Diana Zaffalon, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5pMaider Apodaka-Biguri, André L Simão, Francisco González-Romero, et al.
The American Journal of Gastroenterology|November 20, 2023
Effectiveness of Helicobacter pylori Treatments According to Antibiotic ResistanceLuis Bujanda, Olga P Nyssen, June Ramos, et al.
Scandinavian Journal of Gastroenterology|October 22, 2010
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)Miguel A Montoro, Lawrence J Brandt, Santos Santolaria, et al.
Pageof 43

Showing results (351-360 of 423) with videos related to

Sort By:
Pageof 43
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severityPhilip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 3, 2021
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involvedLuis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
Helicobacter|July 14, 2020
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)Olga P Nyssen, Angeles Perez-Aisa, Luis Rodrigo, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
The Role of Statins on <i>Helicobacter pylori</i> Eradication: Results from the European Registry on the Management of <i>H. pylori</i> (Hp-EuReg)María Caldas, Ángeles Pérez-Aisa, Bojan Tepes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 13, 2019
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of PatientsAdrian G McNicholl, Dmitry S Bordin, Alfredo Lucendo, et al.
BJS Open|March 31, 2026
Accuracy and variability of locoregional staging in T1 rectal cancer: nationwide multicentre cohort studyMaria Daca-Alvarez, Cristina Manzotti, Diana Zaffalon, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5pMaider Apodaka-Biguri, André L Simão, Francisco González-Romero, et al.
The American Journal of Gastroenterology|November 20, 2023
Effectiveness of Helicobacter pylori Treatments According to Antibiotic ResistanceLuis Bujanda, Olga P Nyssen, June Ramos, et al.
Scandinavian Journal of Gastroenterology|October 22, 2010
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)Miguel A Montoro, Lawrence J Brandt, Santos Santolaria, et al.
Pageof 43